Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
PUT
Semtech
SMTC
$9.68B
| $483K | ﹤0.01% |
10,700
-17,700
| -62% | -$630K |
|
4827
Verrica Pharmaceuticals
VRCA
$92.9M
| $481K | ﹤0.01% |
90,708
+51,143
| +129% | +$275K |
|
4828
Montauk Renewables
MNTK
$253M
| $480K | ﹤0.01% |
216,078
+193,185
| +844% | +$409K |
|
4829
Nano X Imaging
NNOX
$64.5M
| $479K | ﹤0.01% |
92,639
-8,480
| -8% | -$43.2K |
|
4830
MKS Inc
MKSI
$17.5B
| $479K | ﹤0.01% |
4,816
-540,293
| -99% | -$43.9M |
|
4831
CervoMed
CRVO
$22.9M
| $478K | ﹤0.01% |
+76,080
| New | +$648K |
|
4832
CALL
Neogen
NEOG
$2.01B
| $478K | ﹤0.01% |
+100,000
| New | +$574K |
|
|
CNL
4833
Collective Mining Ltd
CNL
$1.12B
| $478K | ﹤0.01% |
43,677
-72,198
| -62% | -$732K |
|
4834
American Vanguard Corp
AVD
$72.1M
| $475K | ﹤0.01% |
121,218
-153,179
| -56% | -$639K |
|
4835
CALL
Antero Midstream
AM
$10.3B
| $474K | ﹤0.01% |
25,000
-48,600
| -66% | -$868K |
|
4836
Alvotech
ALVO
$1.19B
| $472K | ﹤0.01% |
51,709
+22,836
| +79% | +$214K |
|
4837
CALL
Aptiv
APTV
$12.3B
| $471K | ﹤0.01% |
6,900
-193,500
| -97% | -$12M |
|
4838
CALL
Immunocore
IMCR
$1.68B
| $471K | ﹤0.01% |
+15,000
| New | +$466K |
|
4839
Community Bank
CBU
$3.43B
| $467K | ﹤0.01% |
8,220
-25,397
| -76% | -$1.41M |
|
4840
Eledon Pharmaceuticals
ELDN
$258M
| $465K | ﹤0.01% |
171,669
-639,207
| -79% | -$1.92M |
|
4841
Star Group
SGU
$420M
| $464K | ﹤0.01% |
39,658
+27,377
| +223% | +$337K |
|
4842
CALL
Modine Manufacturing
MOD
$9.81B
| $463K | ﹤0.01% |
4,700
| – | – |
|
4843
Gaotu Techedu
GOTU
$403M
| $463K | ﹤0.01% |
128,223
-1,867,921
| -94% | -$6.41M |
|
4844
Lyell Immunopharma
LYEL
$317M
| $462K | ﹤0.01% |
52,229
+50,081
| +2,332% | +$456K |
|
4845
PUT
BWX Technologies
BWXT
$14.6B
| $461K | ﹤0.01% |
3,200
-5,000
| -61% | -$584K |
|
4846
CALL
HEICO Corp
HEI
$49.3B
| $459K | ﹤0.01% |
1,400
-3,900
| -74% | -$1.08M |
|
|
MLNK
4847
DELISTED
MeridianLink
MLNK
| $456K | ﹤0.01% |
28,092
+17,897
| +176% | +$299K |
|
4848
Riot Platforms
RIOT
$7.22B
| $455K | ﹤0.01% |
40,291
-213,699
| -84% | -$1.82M |
|
|
CVAC
4849
DELISTED
CureVac
CVAC
| $455K | ﹤0.01% |
83,805
-1,733,179
| -95% | -$6.87M |
|
4850
Century Therapeutics
IPSC
$368M
| $454K | ﹤0.01% |
+812,213
| New | +$436K |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.